VEGFA and breast cancer: Initially, ERRα was shown to enhance the growth in situ but repress the proliferation of breast cancer cells in bone via upregulating the osteoclastogenesis inhibitor OPG and angiogenic growth factor VEGF in a mouse xenograft model of metastatic human breast cancer.